Company Ulimed Srl with Fiscal Code 18081962
recorded a turnover of 2024 of
99.191,
with a net profit of
54.230
and having an average number of employees of
1.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Ulimed Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
33.799
33.812
37.650
42.362
51.938
50.805
63.773
66.532
83.235
99.191
Total Income - EUR
33.801
33.816
37.651
42.363
51.940
51.851
65.267
66.544
84.352
106.251
Total Expenses - EUR
18.582
15.443
20.524
16.006
19.024
18.739
17.782
20.817
30.154
49.105
Gross Profit/Loss - EUR
15.219
18.373
17.127
26.358
32.916
33.112
47.485
45.727
54.198
57.146
Net Profit/Loss - EUR
14.205
17.586
16.757
25.934
32.397
32.778
46.856
45.075
53.371
54.230
Employees
1
1
2
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 19.8%, from 83.235 euro in the year 2023, to 99.191 euro in 2024.
The Net Profit increased by 1.157 euro, from 53.371 euro in 2023, to 54.230 in the last year.
Check the financial reports for the company - Ulimed Srl
Financial Rating - ULIMED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Ulimed Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Ulimed Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Ulimed Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
142.753 euro in 2024 which includes Inventories of
0 euro, Receivables of
130.575 euro and cash availability of
12.179 euro.
The company's Equity was valued at
54.298 euro, while total Liabilities amounted to
19.234 euro.
Equity increased by 1.157 euro, from 53.440 euro in 2023, to 54.298 in 2024.
The Debt Ratio was 13.0% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Ulimed Srl